THU0209 Efficacy of anti-TNF therapy in 15 patients with refractory takayasu's arteritis: Long term unicentric follow-up

E Tombetti, E Baldissera, S Franchini, F Motta… - Annals of the …, 2013 - ard.bmj.com
Background Takayasu arteritis (TA) is a rare chronic-relapsing granulomatous vasculitis
involving primarily the aorta and its major branches 1. TA is associated with considerable …

Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up

ES Molloy, CA Langford, TM Clark, CE Gota… - Annals of the …, 2008 - ard.bmj.com
Objective: To assess the efficacy of anti-tumour necrosis factor (TNF) therapy to induce
remission in patients with Takayasu arteritis (TAK) refractory to other immunosuppressive …

Takayasu's arteritis progression on anti-TNF biologics: a case series

M Osman, S Aaron, M Noga, E Yacyshyn - Clinical rheumatology, 2011 - Springer
Takayasu's arteritis (TA) is a rare granulomatous vasculitic disease that affects the aorta and
its major branches. Recent studies have suggested that anti-TNFα biological therapies are …

FRI0268 CLINICAL FEATURES OF TAKAYASU'S ARTERITIS FROM AN INCEPTION COHORT: EARLY DISEASE IS CHARACTERIZED BY 'SYSTEMIC …

F Alibaz-Oner, Turkish Takayasu Arteritis Study Group - 2019 - ard.bmj.com
Background: There is only retrospective and very limited data for the long term prognosis of
Takayasu's Arteritis (TAK), a rare large-vessel vasculitis. Objectives: In this study, we aimed …

THU0293 safety and efficacy of short-term treatment with tocilizumab in patients with refractory Takayasu arteritis

P Novikov, I Smitienko, A Elonakov, G Koilubaeva… - 2015 - ard.bmj.com
Background Takayasu arteritis (TAK) is a granulomatous vasculitis that involves aorta and/or
its main branches and usually affects young or middle-aged women (before 50 years of …

Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long‐term followup

J Schmidt, TA Kermani, AK Bacani… - Arthritis Care & …, 2012 - Wiley Online Library
Objective To report a single‐center experience with the use of tumor necrosis factor (TNF)
inhibitors in patients with Takayasu arteritis (TA). Methods We retrospectively studied a …

Anti–tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis

GS Hoffman, PA Merkel, RD Brasington… - … : Official Journal of …, 2004 - Wiley Online Library
Objective Granulomatous inflammation is a typical feature of Takayasu arteritis (TA), and
tumor necrosis factor (TNF) is important in the formation of granulomas. In this study, we …

Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?

A Della Rossa, A Tavoni, G Merlini, C Baldini… - …, 2005 - academic.oup.com
SIR, Takayasu arteritis (TA) is a chronic, idiopathic, inflammatory disease that primarily
affects large vessels [1]. The management of this disorder is largely unresolved, since a …

Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the …

PI Novikov, IO Smitienko, SV Moiseev - Clinical rheumatology, 2013 - Springer
The objective of this study was to report the long-term use of tumor necrosis factor (TNF)
inhibitors in case series of patients with Takayasu's arteritis refractory to standard …

Outcomes of patients with takayasu arteritis treated with infliximab

F Bonilla-Abadía, CA Cañas, AF Echeverri - The Journal of …, 2013 - jrheum.org
Takayasu arteritis (TA) is a chronic vasculitis of unknown etiology involving the aorta and its
main branches. Progression may lead to stenosis or formation of aneurysms1. Current …